Sharjah boy conquers autism with new therapy

Child is one of 3,000 worldwide treated with GcMAF protein

Last updated:
4 MIN READ
Supplied
Supplied
Supplied
Dose of relief
Starting point

Next month, Dr Bradstreet will be a keynote speaker at the GcMAF Immunology Conference in Dubai, held between December 6 and 7. He tells GN Focus, "I will present our evidence on what causes the symptoms we label autism." He will also talk about his first peer-reviewed research paper on the efficacy of GcMAF on autism. He says, "GcMAF is a potent tool that when properly applied has the capacity to do some amazing things and we are only beginning to understand its healing capacity."

Related Topics:

Sign up for the Daily Briefing

Get the latest news and updates straight to your inbox

Up Next